文献速递心血管胸部CT

主动脉二尖瓣连续性钙化对经导管主动脉瓣置换术后风险评分的增量价值

Incremental Value of Aortomitral Continuity Calcification for Risk Assessment after Transcatheter Aortic Valve Replacement.
PubMed 文献 · Radiol Cardiothorac Imaging · 2019-12-19

回顾性评估329例2013年3月至2016年3月接受TAVR的患者,用术前CT量化主动脉二尖瓣连续性钙化(AMCC)、主动脉瓣钙化(AVC)和冠状动脉钙化(CAC),分析其与1年全因死亡、瓣周漏和住院超过7天的关联。结果显示CAC评分和AMCC质量与1年死亡相关,AVC质量与瓣周漏相关,仅STS评分与住院延长相关;AMCC加入STS评分和AVC质量模型后显著改善个体风险分类。

要点

  • AMCC质量每增加500 mg,1年死亡风险HR为1.13,与CAC评分共同提示死亡风险。
  • AVC质量每增加100 mg,术后瓣周漏风险OR为1.93。
  • AMCC加入STS评分和AVC质量模型后显著改善个体风险分类。

核心结论

  • AMCC与TAVR术后1年内死亡相关,加入仅含STS评分和AVC质量的模型后显著改善个体风险分类。

研究设计与样本

  • 回顾性评估329例于2013年3月至2016年3月接受TAVR的患者,术前CT量化AMCC、AVC和CAC,记录术前STS评分,分析其与1年死亡、瓣周漏和住院超过7天的关联。

关键影像表现/征象

  • 术前CT可量化主动脉二尖瓣连续性钙化(AMCC)、主动脉瓣钙化(AVC)和冠状动脉钙化(CAC)。

诊断标准与关键数值

  • CAC评分每500分与1年死亡的HR为1.11,AMCC质量每500 mg与1年死亡的HR为1.13。
  • AVC质量每100 mg与术后瓣周漏的OR为1.93。
  • 仅STS评分与住院超过7天相关,每分OR为1.19。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate the association of aortomitral continuity calcification (AMCC) with all-cause mortality, postprocedural paravalvular leak (PVL), and prolonged hospital stay in patients undergoing transcatheter aortic valve replacement (TAVR).

MATERIALS AND METHODS: The authors retrospectively evaluated 329 patients who underwent TAVR between March 2013 and March 2016. AMCC, aortic valve calcification (AVC), and coronary artery calcification (CAC) were quantified by using preprocedural CT. Pre-procedural Society of Thoracic Surgeons (STS) score was recorded. Associations between baseline AMCC, AVC, and CAC and 1-year mortality, PVL, and hospital stay longer than 7 days were analyzed.

RESULTS: The median follow-up was 415 days (interquartiles, 344-727 days). After 1 year, 46 of the 329 patients (14%) died and 52 (16%) were hospitalized for more than 7 days. Of the 326 patients who underwent postprocedural echocardiography, 147 (45%) had postprocedural PVL. The CAC score (hazard ratio: 1.11 per 500 points) and AMCC mass (hazard ratio: 1.13 per 500 mg) were associated with 1-year mortality. AVC mass (odds ratio: 1.93 per 100 mg) was associated with postprocedural PVL. Only the STS score was associated with prolonged hospital stay (odds ratio: 1.19 per point).

CONCLUSION: AMCC is associated with mortality within 1 year after TAVR and substantially improves individual risk classification when added to a model consisting of STS score and AVC mass only.Supplemental material is available for this article.© RSNA, 2019See also the commentary by Brown and Leipsic in this issue.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Willemink MJ, Maret E, Moneghetti KJ, et al. Incremental Value of Aortomitral Continuity Calcification for Risk Assessment after Transcatheter Aortic Valve Replacement. Radiol Cardiothorac Imaging. 2019. PMID: 33778530. doi:10.1148/ryct.2019190067

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。